Intrinsic Value of S&P & Nasdaq Contact Us

The Travelers Companies, Inc. TRV NYSE

NYSE • Financial Services • Insurance - Property & Casualty • US • USD

SharesGrow Score
66/100
2/7 Pass
SharesGrow Intrinsic Value
$553.11
+84.6%
Analyst Price Target
$312.75
+4.4%

The Travelers Companies, Inc. (TRV) is a Insurance - Property & Casualty company in the Financial Services sector, currently trading at $299.59. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of TRV = $553.11 (+84.6% from the current price, the stock appears undervalued). Analyst consensus target is TRV = $313 (+4.4% upside).

Valuation: TRV trades at a trailing Price-to-Earnings (P/E) of 10.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.58.

Financials: revenue is $48.8B, +9.9%/yr average growth. Net income is $6.3B, growing at +32.7%/yr. Net profit margin is 12.9% (healthy). Gross margin is 44.3% (-55.7 pp trend).

Balance sheet: total debt is $9.3B against $32.9B equity (Debt-to-Equity (D/E) ratio 0.28, conservative). Current ratio is 0.23 (tight liquidity). Debt-to-assets is 6.4%. Total assets: $143.7B.

Analyst outlook: 13 / 43 analysts rate TRV as buy (30%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 58/100 (Partial), Growth 83/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 62/100 (Partial), Future 34/100 (Fail), Income 55/100 (Partial).

$312.75
▲ 4.39% Upside
Average Price Target
Based on 43 Wall Street analysts offering 12-month price targets for The Travelers Companies, Inc., the average price target is $312.75, with a high forecast of $317.00, and a low forecast of $304.00.
Highest Price Target
$317.00
Average Price Target
$312.75
Lowest Price Target
$304.00

TRV SharesGrow Score Overview

66/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 58/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 62/100
Gross margin is + market cap
FUTURE 34/100
Analyst outlook — as buy
INCOME 55/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TRV

~
VALUE Partial
58/100
TRV trades at a trailing Price-to-Earnings (P/E) of 10.6 (S&P 500 average ~25). Forward PEG 2.58 — overvalued. Trailing PEG 1.28. Analyst consensus target is $313, implying +4.5% from the current price $300. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
83/100
TRV: +9.9%/yr revenue is, +32.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
TRV: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet TRV: Debt-to-Equity (D/E) ratio 0.28 (conservative), Current ratio is 0.23 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
62/100
TRV: Gross margin is 44.3% (-55.7 pp trend), $65B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 62/100. ≥ 70 = Pass.
View details →
FUTURE Fail
34/100
Analyst outlook: 13 / 43 analysts rate TRV as buy (30%). Analyst consensus target is $313 (+4.5% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
55/100
TRV: Net profit margin is 12.9%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range230.43-313.12
Volume1.09M
Avg Volume (30D)1.57M
Market Cap$64.78B
Beta (1Y)0.52
Dividend Yield$4.4000
Share Statistics
EPS (TTM)27.84
Shares Outstanding$224.2M
IPO Date1975-11-17
Employees34,000
CEOAlan David Schnitzer
Financial Highlights & Ratios
Revenue (TTM)$48.83B
Gross Profit$21.61B
EBITDA$8.9B
Net Income$6.29B
Operating Income$7.8B
Total Cash$6.56B
Total Debt$9.27B
Net Debt$8.43B
Total Assets$143.71B
Price / Earnings (P/E)10.8
Price / Sales (P/S)1.33
Analyst Forecast
1Y Price Target$315.00
Target High$317.00
Target Low$304.00
Upside+5.1%
Rating ConsensusHold
Analysts Covering43
Buy 30% Hold 63% Sell 7%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS89417E1091

Price Chart

TRV
The Travelers Companies, Inc.  ·  NYSE
Financial Services • Insurance - Property & Casualty
230.43 52WK RANGE 313.12
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message